CimaVax EGF IH1_Z AH0 V_AE2_K_S_IY1_N Y_UW1_Z_D T_UW1 T_R_IY1_T K_AE1_N_S_ER0    S_P_AH0_S_IH1_F_IH0_K_L_IY0 N_AA1_N S_M_AO1_L S_EH1_L L_AH1_NG K_AA2_R_S_AH0_N_OW1_M_AH0    NSCLC    CIMAvax EGF IH1_Z K_AH0_M_P_OW1_Z_D AH1_V R_IH0_K_AA1_M_B_IH0_N_AH0_N_T HH_Y_UW1_M_AH0_N EH2_P_IH0_D_ER1_M_AH0_L G_R_OW1_TH F_AE1_K_T_ER0    EGF    K_AA2_N_JH_AH0_G_EY1_T_IH0_D T_UW1 AH0 P_R_OW1_T_IY2_N K_AE1_R_IY0_ER0    The V_AE2_K_S_IY1_N W_AA1_Z D_IH0_V_EH1_L_AH0_P_T B_AY1 DH_AH0 Center AH1_V Molecular Immunology    Havana    Cuba     There AA1_R AH0_G_R_IY1_M_AH0_N_T_S IH0_N P_L_EY1_S T_UW1 T_EH1_S_T IH1_T IH0_N DH_AH0 United States    Japan    AH0_N_D S_AH1_M European K_AH1_N_T_R_IY0_Z    It IH1_Z K_ER1_AH0_N_T_L_IY0 AH0_V_EY1_L_AH0_B_AH0_L IH0_N Cuba    Colombia    Bosnia AH0_N_D Herzegovina    Peru AH0_N_D Paraguay    In October 2015 Serbia EH1_S Institute AH1_V Virology    Vaccines AH0_N_D Sera    AKA Torlak Institute    S_AY1_N_D AH0 M_EH2_M_ER0_AE1_N_D_AH0_M F_AO1_R Y_UW1_S IH0_N 30 P_EY1_SH_AH0_N_T_S AE1_Z P_AA1_R_T AH1_V AH0 S_T_AH1_D_IY0    CimaVax IH1_Z R_EH1_L_AH0_T_IH0_V_L_IY0 CH_IY1_P T_UW1 P_R_AH0_D_UW1_S AH0_N_D S_T_AO1_R    AH0_N_D HH_AE1_Z L_OW1 T_AA0_K_S_IH1_S_AH0_T_IY0    Side IH0_F_EH1_K_T_S AH1_V DH_AH0 V_AE2_K_S_IY1_N AH0_P_IH1_R T_UW1 B_IY1 M_AY1_L_D    AH0_N_D IH2_N_K_L_UW1_D CH_IH1_L_Z    F_IY1_V_ER0    AH0_N_D F_IY1_L_IH0_NG S_IH1_K     CimaVax IH1_Z AE1_N AE1_K_T_IH0_V V_AE2_K_S_IY1_N W_IH1_DH W_IH1_CH P_EY1_SH_AH0_N_T_S AA1_R IH1_M_Y_AH0_N_AY2_Z_D W_IH1_DH EH2_P_IH0_D_ER1_M_AH0_L G_R_OW1_TH F_AE1_K_T_ER0    EGF     DH_AH1_S R_EY1_Z_IH0_NG AE1_N_T_IH0_B_AA2_D_IY0_Z T_AA1_R_G_AH0_T_IH0_NG EGF IH2_T_S_EH1_L_F The P_R_AA1_D_AH0_K_T IH1_Z AO1_L_S_OW0 F_AO1_R_M_Y_AH0_L_EY2_T_AH0_D W_IH1_DH DH_AH0 Neisseria meningitidis AW1_T_ER0 P_R_OW1_T_IY2_N P64k AH0_N_D Montanide ISA 51 AE1_Z adjuvants T_UW1 potentiate DH_AH0 IH2_M_Y_UW1_N R_IH0_S_P_AA1_N_S     The EH2_P_IH0_D_ER1_M_AH0_L G_R_OW1_TH F_AE1_K_T_ER0 R_IY0_S_EH1_P_T_ER0    EGFR    IH1_Z HH_AY1_JH_AE2_K_T B_AY1 M_EH1_N_IY0 T_AY1_P_S AH1_V K_AE1_N_S_ER0    IH2_N_K_L_UW1_D_IH0_NG K_AE1_N_S_ER0_Z AH1_V DH_AH0 L_AH1_NG    K_OW1_L_AH0_N    K_IH1_D_N_IY0    AH0_N_D HH_EH1_D AH0_N_D N_EH1_K By R_EY1_Z_IH0_NG AE1_N_T_IH0_B_AA2_D_IY0_Z AH0_G_EH1_N_S_T EGF    W_IH1_CH IH1_Z EGFR EH1_S M_EY1_JH_ER0 L_IH1_G_AH0_N_D    DH_AH0 K_AA2_N_S_AH0_N_T_R_EY1_SH_AH0_N_Z AH1_V EGF IH0_N DH_AH0 B_L_AH1_D AA1_R R_IH0_D_UW1_S_T Thus CimaVax D_AH1_Z N_AA1_T T_AA1_R_G_AH0_T DH_AH0 K_AE1_N_S_ER0 S_EH1_L_Z D_ER0_EH1_K_T_L_IY0    B_AH1_T IH1_Z IH0_K_S_P_EH1_K_T_AH0_D T_UW1 W_ER1_K AH0_G_EH1_N_S_T DH_IY1_Z K_AE1_N_S_ER0_Z B_AY1 D_IH0_N_AY1_IH0_NG DH_AH0 K_AE1_N_S_ER0_Z DH_AH0 G_R_OW1_TH S_T_IH1_M_Y_AH0_L_AH0_S DH_EY1 R_IY2_K_W_AY1_ER0     For DH_IH1_S R_IY1_Z_AH0_N    DH_AH0 Roswell Park G_R_UW1_P TH_IH1_NG_K_S DH_AE1_T IH1_T M_EY1 P_R_UW1_V M_OW1_S_T Y_UW1_S_F_AH0_L AE1_Z AH0 P_R_IH0_V_EH1_N_T_IH0_V V_AE2_K_S_IY1_N R_AE1_DH_ER0 DH_AE1_N AE1_Z AH0 K_AE1_N_S_ER0 TH_EH1_R_AH0_P_IY0 P_ER1 S_EY1    Early T_R_AY1_AH0_L_Z SH_OW1_D AH0 T_R_EH1_N_D T_AH0_W_AO1_R_D_Z IH2_M_P_R_UW1_V_D S_ER0_V_AY1_V_AH0_L AH0_M_AH1_NG V_AE1_K_S_AH0_N_EY0_T_IH0_D T_EH1_S_T S_AH1_B_JH_IH0_K_T_S     D_ER0_EH1_K_T K_AO2_R_AH0_L_EY1_SH_AH0_N B_IH0_T_W_IY1_N DH_AH0 L_EH1_V_AH0_L AH1_V AE1_N_T_IH0_B_AA2_D_IY0_Z DH_AE1_T AH0 V_AE1_K_S_AH0_N_EY0_T_IH0_D P_EY1_SH_AH0_N_T R_EY1_Z_AH0_Z AH0_G_EH1_N_S_T EGF AH0_N_D S_ER0_V_AY1_V_AH0_L HH_AE1_Z B_IH1_N AH0_B_Z_ER1_V_D IH0_N S_EH1_V_ER0_AH0_L T_R_AY1_AH0_L_Z     AH0_N_D IH0_N W_AH1_N AH1_V DH_AH0 L_AA1_R_JH_AH0_S_T T_R_AY1_AH0_L_Z    DH_EH1_R W_AA1_Z AO1_L_S_OW0 AE1_N EY1_JH D_IH0_P_EH1_N_D_AH0_N_S    W_IH1_DH OW1_N_L_IY0 S_AH1_B_JH_IH0_K_T_S AH1_N_D_ER0 DH_AH0 EY1_JH AH1_V 60 B_EH1_N_AH0_F_IH0_T_IH0_NG IH0_N T_ER1_M_Z AH1_V S_ER0_V_AY1_V_AH0_L    More AE1_N_T_IH0_B_AA2_D_IY0_Z AA1_R R_EY1_Z_D W_EH1_N DH_AH0 V_AE2_K_S_IY1_N IH1_Z F_AO1_R_M_Y_AH0_L_EY2_T_AH0_D W_IH1_DH Montanide ISA 51 R_AE1_DH_ER0 DH_AE1_N AH0_L_UW1_M_AH0_N_AH0_M HH_AY0_D_R_AA1_K_S_AY0_D    AE1_Z AE1_N adjuvant    AH0_N_D W_EH1_N P_EY1_SH_AH0_N_T_S R_AH0_S_IY1_V AH0 L_OW1 D_OW1_S AH1_V cyclophosphamide TH_R_IY1 D_EY1_Z B_IH0_F_AO1_R V_AE2_K_S_IY1_N AE0_D_M_IH2_N_IH0_S_T_R_EY1_SH_AH0_N    Cyclophosphamide IH1_Z TH_AO1_T T_UW1 T_EH2_M_P_ER0_EH1_R_AH0_L_IY0 B_L_AA1_K DH_AH0 B_AA1_D_IY0 EH1_S N_AE1_CH_ER0_AH0_L IH2_M_Y_UW1_N T_AA1_L_ER0_AH0_N_S T_UW1 EGF    DH_EH1_R_B_AY1 IH2_N_K_R_IY1_S_IH0_NG AE1_N_T_IH0_B_AA2_D_IY0 titers    Researchers K_AA1_SH_AH0_N DH_AE1_T DH_AH0 ER1_L_IY0 R_IH0_Z_AH1_L_T_S T_UW1 D_EY1_T HH_AE1_V B_IH1_N IH0_N R_EH1_L_AH0_T_IH0_V_L_IY0 S_M_AO1_L    ER1_L_IY0 S_T_EY1_JH T_R_AY1_AH0_L_Z W_IH1_DH P_EY1_SH_AH0_N_T_S DH_AE1_T W_ER1 K_EH1_R_F_AH0_L_IY0 S_AH0_L_EH1_K_T_AH0_D B_EY1_S_T AA1_N predefined IH2_N_K_L_UW1_ZH_AH0_N AH0_N_D IH0_K_S_K_L_UW1_ZH_AH0_N K_R_AY0_T_IH1_R_IY0_AH0    AH0_N_D G_IH1_V_AH0_N S_P_EH1_SH_AH0_L_AY2_Z_D AA0_NG_K_AA1_L_AH0_JH_IY0 K_EH1_R ;  DH_EY1 M_EY1 DH_EH1_R_F_AO2_R N_AA1_T B_IY1 R_EH2_P_R_AH0_Z_EH1_N_T_AH0_T_IH0_V AH1_V M_OW1_S_T P_EY1_SH_AH0_N_T_S HH_UW1 M_AY1_T B_EH1_N_AH0_F_IH0_T F_R_AH1_M DH_AH0 V_AE2_K_S_IY1_N    It HH_AE1_Z B_IH1_N ER1_JH_D DH_AE1_T CimaVax B_IY1 T_EH1_S_T_IH0_D IH0_N P_EY1_SH_AH0_N_T_S W_IH1_DH ER1_L_IY0_ER0 S_T_EY1_JH NSCLC K_AE1_N_S_ER0 AH0_N_D IH0_N P_EY1_SH_AH0_N_T_S HH_UW1 AA1_R N_AA1_T K_AE1_N_D_AH0_D_EY0_T_S F_AO1_R K_IY2_M_OW0_TH_EH1_R_AH0_P_IY0    AH0_N_D DH_AE1_T R_IY0_S_ER1_CH B_IY1 K_AH0_N_D_AH1_K_T_AH0_D T_UW1 D_AH0_T_ER1_M_AH0_N W_IH1_CH S_AH1_B_G_R_UW2_P_S AH1_V NSCLC P_EY1_SH_AH0_N_T_S D_UW1 AH0_N_D D_AA1_N T_IY1 R_IH0_S_P_AA1_N_D T_UW1 DH_AH0 V_AE2_K_S_IY1_N    It HH_AE1_Z B_IH1_N S_AH0_JH_EH1_S_T_AH0_D DH_AE1_T CimaVax M_EY1 AO1_L_S_OW0 B_IY1 IH0_F_EH1_K_T_IH0_V IH0_N AH1_DH_ER0 T_AY1_P_S AH1_V K_AE1_N_S_ER0 DH_AE1_T AA1_R D_IH0_P_EH1_N_D_AH0_N_T AA1_N EGF EGFR    IH2_N_K_L_UW1_D_IH0_NG M_EH1_N_IY0 K_EY1_S_AH0_Z AH1_V P_R_AA1_S_T_EY2_T K_AE1_N_S_ER0    Trials AA1_R B_IY1_IH0_NG AO1_R_G_AH0_N_AY2_Z_D IH0_N DH_AH0 United States    DH_AH0 European Union    Japan     AH0_N_D Serbia    In L_EY1_T October 2016    DH_AH0 United States Food AH0_N_D Drug Administration AO1_TH_ER0_AY2_Z_D    DH_AH0 Roswell Park Cancer Institute T_UW1 K_AA1_N_D_AH0_K_T AH0 PhaseI II K_L_IH1_N_AH0_K_AH0_L T_R_AY1_AH0_L AH1_V CimaVAX IH0_N P_EY1_SH_AH0_N_T_S W_IH1_DH N_AA1_N S_M_AO1_L S_EH1_L L_AH1_NG K_AE1_N_S_ER0    By DH_AH0 M_IH1_D_AH0_L AH1_V DH_AH0 F_AA1_L_OW0_IH0_NG M_AH1_N_TH    N_IH1_R_L_IY0 200 P_IY1_P_AH0_L HH_AE1_D V_AA2_L_AH0_N_T_IH1_R_D T_UW1 B_IY1 S_AH1_B_JH_IH0_K_T_S IH0_N DH_AH0 T_R_AY1_AH0_L   